HTA26 Health Technology Assessment (HTA) Methods for Monoclonal Antibodies for Treatment and Prevention of COVID-19 von Warttig, S, Ling, C

Volltext

HTA195 Analysis of Health Technology Assessment (HTA) Procedures and Outcomes for Orphan Drugs von Warttig, S, D'Souza, V

Volltext

HTA10 HTA Considerations for Large Language Models in Healthcare von Leonard, C., Unsworth, H., Warttig, S., Gildea, L., Mordin, M., Ling, C.

Volltext

MT61 Differences and Similarities of Health Economic Evaluation for Medical Technologies By HTA Bodies von D'Souza, V., Gildea, L., Mordin, M., Long, J., Kinderas, M., Ling, C., Warttig, S., Hartley, L.

Volltext

MT29 Understanding How Health Technology Assessment Bodies Select Medical Technology for Review: Results of an Online Survey von Gildea, L., Mordin, M., Long, J., D'Souza, V., Kinderas, M., Warttig, S., Hartley, L., Ling, C.

Volltext

MT25 What Evidence Should Medical Technology Companies Expect HTA Bodies to Review? von Mordin, M., Gildea, L., Long, J., D'Souza, V., Kinderas, M., Ling, C., Warttig, S., Hartley, L.

Volltext

MT44 Submission Process and Requirements of Nordic Health Technology Assessment Organisations for Medical Technologies: Results of an Online Survey von Kinderås, M., Gildea, L., Mordin, M., Long, J., D'Souza, V., Ling, C., Warttig, S., Hartley, L.

Volltext

MT13 Digging into the Medical Technology HTA Process in Tunisia von Mordin, M., Warttig, S., Gildea, L., Long, J., D'Souza, V., Kinderas, M., Ling, C., Hartley, L.

Volltext

MT43 Does Real-World Evidence Play a Role in Decision-Making by HTA Bodies for Medical Technologies? von Hartley, L., Gildea, L., Mordin, M., Long, J., D'Souza, V., Kinderas, M., Ling, C., Warttig, S.

Volltext

MT26 HTA Requirements for Medical Technologies in Canada von Mordin, M, Bhogal, P, Warttig, S, Gildea, L, Long, J, D'Souza, V, Kinderas, M, Ling, C, Hartley, L

Volltext

MT16 What Is the Medical Technology HTA Process in Japan? von Mordin, M, Bhogal, P, Warttig, S, Gildea, L, Long, J, D'Souza, V, Kinderas, M, Ling, C, Hartley, L

Volltext

MT41 Process and Requirements for Submitting Nonpharmaceutical Medical Technologies to Health Technology Assessment Authorities von Costello, J, D'Souza, V, Gildea, L, Kinderås, M, Ling, C, Marcano Belisario, J, Warttig, S

Volltext

062 Partially Updating a Guideline to Improve its Implementation von Warttig, S, Elliott, N

Volltext

HTA74 HTA Processes for Medical Technologies across the World – Are All Hurdles the Same? von Mordin, M., Gildea, L., Warttig, S., Costello, J., D'Souza, V., Kinderås, M., Ling, C., Marcano Belisario, J.

Volltext

Diagnosis and management of gallstone disease: summary of NICE guidance von Warttig, Sheryl, Ward, Steven, Rogers, Gabriel

Volltext

Donor identification and consent for deceased organ donation: summary of NICE guidance von Chamberlain, K, Baker, M R, Kandaswamy, P, Shaw, E J, McVeigh, G, Siddiqui, F

Volltext

New, normative, English-sample data for the Short Form Perceived Stress Scale (PSS-4) von Warttig, Sheryl L, Forshaw, Mark J, South, Jane, White, Alan K

Volltext

Warming of intravenous and irrigation fluids for preventing inadvertent perioperative hypothermia von Campbell, Gillian, Alderson, Phil, Smith, Andrew F, Warttig, Sheryl, Campbell, Gillian

Volltext

Interventions for treating inadvertent postoperative hypothermia von Warttig, Sheryl, Alderson, Phil, Campbell, Gillian, Smith, Andrew F, Warttig, Sheryl

Volltext

Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients von Warttig, Sheryl, Alderson, Phil, Evans, David JW, Lewis, Sharon R, Kourbeti, Irene S, Smith, Andrew F, Warttig, Sheryl

Volltext